Close
Publicación

Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2.

Ver todas las publicaciones
Not available in
This is not available in . You can go to the translated versions in these languages: